Clinical Trial Update: Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing a carfilzomib-containing regimen (carfilzomib, lenalidomide, dexamethasone) versus lenalidomide alone after stem-cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (Kyprolis) (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING